Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Med Mycol ; 50(4): 439-45, 2012 May.
Article in English | MEDLINE | ID: mdl-22070341

ABSTRACT

In this study we present the results of a therapeutic drug monitoring retrospective analysis involving 14 patients with several underlying diseases who were receiving voriconazole for the treatment of fungal infections. A simple high performance liquid chromatography assay with ultraviolet detection was used in the drug monitoring. We report here that serum concentrations were highly variable and unpredictable in most patients. We also found that lack of response was more frequent in patients with levels persistently lower than 1 mg/l. The number of samples with voriconazole concentrations below 1 mg/l was significantly higher in patients who exhibited therapeutic failures (88% versus 27%; P < 0.001). In addition, the period of time in which voriconazole concentrations were maintained below 1 mg/l was slightly higher in patients in the failure group. We suggest that serum concentration should be individually quantified for patients receiving voriconazole therapy. Further prospective studies are needed to clarify the potential benefit of the individualization of treatment.


Subject(s)
Antifungal Agents/administration & dosage , Antifungal Agents/pharmacokinetics , Pyrimidines/administration & dosage , Pyrimidines/pharmacokinetics , Serum/chemistry , Triazoles/administration & dosage , Triazoles/pharmacokinetics , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Chromatography, High Pressure Liquid/methods , Drug Monitoring/methods , Female , Humans , Male , Middle Aged , Mycoses/drug therapy , Retrospective Studies , Time Factors , Voriconazole , Young Adult
6.
Antimicrob Agents Chemother ; 22(6): 1064-6, 1982 Dec.
Article in English | MEDLINE | ID: mdl-6818899

ABSTRACT

The in vitro synergistic activity of N-formimidoyl thienamycin and amikacin was determined against gentamicin-resistant enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus aureus. N-Formimidoyl thienamycin showed synergism with amikacin against 19 of the gentamicin-resistant strains, 14 of the 49 strains of S. aureus, and only 1 strain of the 46 P. aeruginosa isolates.


Subject(s)
Amikacin/pharmacology , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Kanamycin/analogs & derivatives , Staphylococcus aureus/drug effects , Thienamycins/pharmacology , Drug Resistance, Microbial , Drug Synergism , Enterobacteriaceae/drug effects , Gentamicins/pharmacology , Imipenem , Pseudomonas aeruginosa/drug effects
7.
Antimicrob Agents Chemother ; 21(3): 501-3, 1982 Mar.
Article in English | MEDLINE | ID: mdl-6980624

ABSTRACT

IN vitro susceptibilities of 98 isolates of Brucella melitensis to N-formimidoyl thienamycin, tetracycline, co-trimoxazole, rifampin, and cefoxitin were determined. N-Formimidoyl thienamycin showed good activity which was similar to those of tetracycline and rifampin and different from that of the other beta-lactam antibiotic tested (cefoxitin), which showed poor activity. Co-trimoxazole showed good activity.


Subject(s)
Anti-Bacterial Agents/pharmacology , Brucella/drug effects , Brucellosis/microbiology , Cefoxitin/pharmacology , Drug Combinations/pharmacology , Humans , Imipenem , Lactams/pharmacology , Microbial Sensitivity Tests , Rifampin/pharmacology , Sulfamethoxazole/pharmacology , Tetracycline/pharmacology , Trimethoprim/pharmacology , Trimethoprim, Sulfamethoxazole Drug Combination
SELECTION OF CITATIONS
SEARCH DETAIL
...